there is so much we will never know about the mechanisms behind the scenes, and we shouldnt know anyway. if there are multiple NDAs with potential partners, then so be it. we seem to think that public knowledge of NASH 700 results would ramp up excitement and potential bidding numbers, but anything less than 100% stellar data can result in detractors saying its not enough. i am at this point fully trusting the board to execute their plan wisely. we got too used to nader blurting out every single detail possible, every 2 weeks. most of the time, it hurt the stock price. now, the cards are held closely to the chest. good.

hopefully one small element of the new strategy of silence is to purposely built up tension. withholding NASH 700 results is frustrating for us right now, but im betting on a media blitz at some point that will will release a wall of good news all at once. we have seen how bits and pieces of certain news gets announced over the last two years that can give a temporary boost but eventually get bled back to where we were previously, because OTC. hopefully the amerex situation can be massaged into letting the FDA cover their arses, so then the FDA can say that they believed in us all along. we all know at the very least leronlimab data is solid and safe enough to warrant EUA for covid/long haulers TODAY, but too many obstacles have prevented that. i want to believe that current management has the fire inside them that nader has to burn those responsible for our stalled success. burn baby burn.